Amplifon S.p.A EBITDA 2019-2024 | AMFPF

Amplifon S.p.A EBITDA for the quarter ending September 30, 2024 was $0.147B, a 105.91% increase year-over-year.

  • Amplifon S.p.A 2024 EBITDA was 0.607B, a 6.48% increase from 2023.
  • Amplifon S.p.A 2023 EBITDA was 0.57B, a 4.34% increase from 2022.
  • Amplifon S.p.A 2022 EBITDA was 0.547B, a 1.39% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Amplifon S.p.A EBITDA 2019-2024 | AMFPF

  • Amplifon S.p.A 2024 EBITDA was 0.607B, a 6.48% increase from 2023.
  • Amplifon S.p.A 2023 EBITDA was 0.57B, a 4.34% increase from 2022.
  • Amplifon S.p.A 2022 EBITDA was 0.547B, a 1.39% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$136B
CVS Health (CVS)$78.4B
Elevance Health (ELV)$62.4B
Cencora (COR)$56.8B
DiDi Global (DIDIY)$26.9B
Labcorp Holdings (LH)$20.4B
Natera (NTRA)$19B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$14B
CochLear (CHEOY)$13.1B
Solventum (SOLV)$12.7B
ICON (ICLR)$11.6B
Revvity (RVTY)$11B
Viatris (VTRS)$10.4B
Avantor (AVTR)$9.1B
Medpace Holdings (MEDP)$9B
Sonic Healthcare (SKHHY)$8.9B
HealthEquity (HQY)$8.4B
Caris Life Sciences,�Inc (CAI)$7.7B
Charles River Laboratories (CRL)$7.6B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.1B
Surgery Partners (SGRY)$2.9B
Concentras Parent (CON)$2.5B
Organon (OGN)$2.5B
Alignment Healthcare (ALHC)$2.5B
GeneDx Holdings (WGS)$2.2B
Progyny (PGNY)$1.9B
PACS (PACS)$1.8B